SCHEMBL14527005

SCHEMBL14527005

CCN1C(=O)S/C(=C/c2ccccc2)C1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.67
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
CISD1 Q9NZ45 2/20 0.58
AKR1B1 P15121 4/20 0.58
HPGD P15428 1/20 0.58
MYC P01106 1/20 0.57
MAX P61244 1/20 0.57
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
MAPT P10636 2/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
MGAM O43451 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
ENPP2 Q13822 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13657861 0.91 AKR1B1 (0.71) ALDH1A1MAOAMAOBCISD1AKR1B1
SCHEMBL14560445 0.85 MAOA (0.65) ALDH1A1MAOAMAOBCISD1AKR1B1
SCHEMBL24129903 0.84 CISD1 (0.67) ALDH1A1MAOAMAOBCISD1MEN1
SCHEMBL2447131 0.84 CISD1 (0.67) ALDH1A1MAOAMAOBCISD1MEN1
SCHEMBL2447134 0.84 CISD1 (0.67) ALDH1A1MAOAMAOBCISD1MEN1
SCHEMBL3284901 0.83 ENPP2 (0.74) ALDH1A1MAOAMAOBMEN1KMT2A
SCHEMBL3284905 0.83 ENPP2 (0.74) ALDH1A1MAOAMAOBMEN1KMT2A
SCHEMBL2622650 0.82 MAOA (0.74) ALDH1A1MAOAMAOBCISD1HPGD
SCHEMBL15816744 0.81 MAOA (0.69) MAOAMAOBCISD1AKR1B1MEN1
SCHEMBL9011343 0.81 AKR1B1 (0.84) AKR1B1MAPTCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078172-A1 MAO-B INHIBITORS USEFUL FOR TREATING OBESITY JENRIN DISCOVERY (US) 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078172-A1 MAO-B INHIBITORS USEFUL FOR TREATING OBESITY MAOB, MAOA, GPR119 ALDH1A1 664/4885MAOA 2/4885MAOB 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.